Rhythm Pharmaceuticals, Inc.
RYTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001649904
In the last 90 days, Rhythm Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 305 institutions reported holding it in 13F filings for Q2 2026, worth $8.55B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Rhythm Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 124 | 105 | −19 |
| Shares | 47.6M | 47.5M | −91.7K (−0.2%) |
| Value | $1.01B | $905.6M | −$106.4M (−10.5%) |
New holders (7)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Assenagon Asset Management S.A. | 142,472 | $2.79M | 0.01% |
| Prudential Financial Inc | 30,973 | $607.0K | 0.00% |
| ACT Capital Management, LLC | 31,000 | $607.0K | 0.31% |
| Winton Group Ltd | 16,863 | $330.0K | 0.02% |
| ExodusPoint Capital Management, LP | 14,944 | $293.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 13,844 | $271.0K | 0.00% |
| Meeder Asset Management Inc | 6,078 | $119.0K | 0.01% |
Sold out (26)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.